MoneyWorks4Me

Jenburkt Pharmaceuticals informs about board meeting

25 Jan 2020 Evaluate

Jenburkt Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 07/02/2020 to consider and approve unaudited financial results of the Company for the quarter and nine months ended on 31st December, 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..